iTonic Holdings (ITOC) Equity Ratio (2023 - 2025)

iTonic Holdings' (ITOC) quarterly Equity Ratio came in at 0.89 in Q4 2025, down 2.88% year-on-year from 0.92 in Q4 2024, and down 3.44% quarter-over-quarter from 0.93 in Q2 2025.

iTonic Holdings (ITOC) Equity Ratio (2023 - 2025) Analysis & Trends

iTonic Holdings has disclosed Equity Ratio across 3 years of filings, most recently posting 0.89 for Q4 2025.

  • Equity Ratio for Q4 2025 came in at 0.89, down 2.88% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.89 (down 2.88% YoY), and the FY2025 annual result was 0.89, down 2.88% from the prior year.
  • Equity Ratio came in at 0.89 for Q4 2025 at iTonic Holdings, down from 0.93 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.93 in Q2 2025 to a low of 0.19 in Q4 2023.
  • The 3-year median for Equity Ratio is 0.91 (2024), against an average of 0.73.
  • Across the five-year window, Equity Ratio soared 385.56% in 2024 and fell 2.88% in 2025, its largest moves.
  • iTonic Holdings' Equity Ratio stood at 0.19 in 2023, then jumped by 385.56% to 0.92 in 2024, then declined by 2.88% to 0.89 in 2025.
  • The last three Equity Ratio figures came in at 0.89 (Q4 2025), 0.93 (Q2 2025), and 0.92 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.47
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.50
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.54
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.42
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.29
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.67
10 iTonic Holdings 5.23 Mn 4.31 Mn - 0.89

Historic Data

Download Data
DateValue
Dec 31, 2025 0.89
Jun 30, 2025 0.93
Dec 31, 2024 0.92
Dec 31, 2023 0.19